COR · Cencora, Inc.
Healthcare NYQ United States cencora.com ↗
BULLISH BUY
Val Gro Qua Mom Sta Cap P/S0.19 P/E Fwd P/E16.08 PEG0.66 52W –  RSI Target$355.83 (+11.7%) Beta0.58 Div0.72%
Loading chart…
RSI (14)
Pattern Overlays
Loading patterns…
Medical Distribution Conshohocken, United States 47,000 employees
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
52-Week Range
52W Low 52W High
Position in Range
RSI (14)
0 · Oversold RSI 67 Overbought · 100
Signal Neutral
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
4Bullish
0Bearish
0Neutral
▲ Double Bottom — Two lows ~$310.78 — bullish reversal confirmed
▲ Double Bottom — Two lows ~$265.30 — bullish reversal confirmed
▲ Bull Flag — Breakout after +9% pole — bullish continuation
▲ Bull Flag — Breakout after +12% pole — bullish continuation

View overlays on the price chart via Chart tab → Pattern Overlays.

Next Earnings Aug 05, 2026
Beat Rate 100%
Consensus BUY
Analyst Upside +11.7%
EPS — History & Forecast
Estimate Beat Miss Forecast
Loading…
Revenue — History & Forecast
Revenue Forecast
Loading…
EPS Beat Rate
100% 8/8 quarters
Wall Street Consensus
BUY
12
2
BuyHoldSell
Price Target Range
$355.83 +11.7% upside
Low $310 High $412
Consensus Current price
Wall Street Analyst Ratings
FirmRatingChangeActionDate
B of A Securities Neutral ↔ Maintain 2026-06-24
Barclays Overweight ↔ Maintain 2026-06-10
Wells Fargo Overweight ↔ Maintain 2026-05-11
UBS Buy ↔ Maintain 2026-05-07
Citigroup Buy ↔ Maintain 2026-05-07
Evercore ISI Group Outperform ↔ Maintain 2026-05-07
Baird Outperform ↔ Maintain 2026-05-07
William Blair Market Perform ● Initiate 2026-04-28
JP Morgan Overweight ↔ Maintain 2026-02-10
Morgan Stanley Overweight Equal-Weight Overweight ▲ Upgrade 2026-01-29
Jefferies Buy Hold Buy ▲ Upgrade 2026-01-22
TD Cowen Buy ↔ Maintain 2025-11-10
Mizuho Outperform ↔ Maintain 2025-11-06
B of A Securities 2026-06-24
Neutral ↔ Maintain
Barclays 2026-06-10
Overweight ↔ Maintain
Wells Fargo 2026-05-11
Overweight ↔ Maintain
UBS 2026-05-07
Buy ↔ Maintain
Citigroup 2026-05-07
Buy ↔ Maintain
Evercore ISI Group 2026-05-07
Outperform ↔ Maintain
Baird 2026-05-07
Outperform ↔ Maintain
William Blair 2026-04-28
Market Perform ● Initiate
JP Morgan 2026-02-10
Overweight ↔ Maintain
Morgan Stanley 2026-01-29
Overweight (from Equal-Weight) ▲ Upgrade
Jefferies 2026-01-22
Buy (from Hold) ▲ Upgrade
TD Cowen 2025-11-10
Buy ↔ Maintain
Mizuho 2025-11-06
Outperform ↔ Maintain
Profitability
Gross Margin 3.80%TTM
Op. Margin 1.72%TTM
ROE 107.13%TTM
Rev. Growth 3.80%YoY
Free Cash Flow -318.25MTTM
FCF Yield TTM
Balance Sheet
Debt / Equity 420.99MRQ
Current Ratio 0.95MRQ
Cash 2.18BMRQ
Total Debt 15.09BMRQ
Net Debt MRQ
Income
Div. Yield 0.72%TTM
Annual Rate 2.40Fwd
Payout Ratio 17.62%TTM
Dividend History
Payout Ratio (TTM): 17.62%
DateAmount / ShareYield at Payment
2026-05-15 $0.6000 0.23%
2026-02-13 $0.6000 0.17%
2025-11-14 $0.6000 0.17%
2025-08-15 $0.5500 0.19%
2025-05-16 $0.5500 0.19%
2025-02-14 $0.5500 0.23%
2024-11-15 $0.5500 0.23%
2024-08-09 $0.5100 0.22%
2024-05-09 $0.5100 0.23%
2024-02-08 $0.5100 0.23%
2023-11-10 $0.5100 0.26%
2023-08-10 $0.4850 0.27%
2023-05-11 $0.4850 0.29%
2023-02-09 $0.4850 0.32%
2022-11-10 $0.4850 0.32%
2022-08-12 $0.4600 0.32%
2022-05-13 $0.4600 0.31%
2022-02-11 $0.4600 0.34%
2021-12-01 $1.2700 1.16%
2021-11-12 $0.4600 0.39%
2021-09-29 $1.2700 1.10%
2021-08-13 $0.4400 0.39%
2021-06-29 $1.2700 1.19%
2021-05-14 $0.4400 0.41%
2021-03-30 $1.2300 1.13%
2021-02-11 $0.4400 0.46%
2020-12-30 $1.2300 1.41%
2020-11-13 $0.4400 0.46%
2020-09-29 $1.2200 1.43%
2020-08-14 $0.4200 0.46%
2020-06-29 $1.2200 1.41%
2020-05-15 $0.4200 0.57%
2020-03-30 $1.2200 1.61%
2020-02-13 $0.4200 0.53%
2019-12-30 $1.2200 1.73%
2019-11-15 $0.4000 0.55%
2019-09-27 $1.2200 1.83%
2019-08-16 $0.4000 0.56%
2019-06-27 $1.2200 1.76%
2019-05-17 $0.4000 0.65%
How COR Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
QuarterRevenueRev YoYGross Profit Op. IncomeNet IncomeNet YoY Gross %Op %Net %
Full Key Statistics
Valuation
Market Cap61.99B
Enterprise Value75.09B
Trailing P/E24.51
Forward P/E16.08
PEG Ratio (5yr)0.66
Price/Sales (ttm)0.19
Price/Book (mrq)18.24
EV/Revenue0.23
EV/EBITDA14.17
Share Statistics
Avg Vol (3m)1.81M
Shares Outstanding194.56M
Float184.00M
% Held by Insiders4.23%
% Held by Institutions98.97%
Short Ratio3.50
Short % of Float3.43%
Profitability
Gross Margin3.80%
Operating Margin (ttm)1.72%
Profit Margin0.78%
Return on Assets (ttm)3.49%
Return on Equity (ttm)107.13%
Income Statement
Revenue (ttm)328.68B
Revenue Growth (yoy)3.80%
Gross Profit (ttm)12.48B
EBITDA5.30B
Net Income (ttm)2.55B
Diluted EPS (ttm)13.00
EPS Growth (yoy)128.30%
Balance Sheet
Total Cash (mrq)2.18B
Total Debt (mrq)15.09B
Debt / Equity (mrq)420.99
Current Ratio (mrq)0.95
Book Value / Share17.46
Operating CF (ttm)2.28B
Free Cash Flow (ttm)-318.25M
Trading & Dividends
Beta (5Y)0.58
50-Day MA285.33
200-Day MA324.58
Fwd Dividend Yield75.00%
Payout Ratio17.62%
Ownership Breakdown
Institutional 98.97% Insider 4.23%
Short Interest 3.43% of float
Moderate
Institutional 13F Holdings

Famous investors who disclosed a position in COR in their latest SEC 13F filing.

Loading…
Insider Transactions
DateInsiderRoleTransactionSharesValue
2026-06-30 BATTAGLIA SILVANA Officer Stock Award(Grant) at price 240.53 per share. 58 $14,000
2026-06-30 CAMPBELL ELIZABETH S Officer Stock Award(Grant) at price 240.53 per share. 49 $12,000
2026-06-22 TYLER LAUREN M. Director Purchase at price 270.23 per share. 550 $148,626
2026-06-18 DURCAN DERMOT MARK Director Purchase at price 274.19 per share. 4,000 $1,096,760
2026-05-28 DURCAN DERMOT MARK Director Purchase at price 266.26 per share. 4,000 $1,065,040
2026-05-01 NALLY DENNIS M Director Stock Award(Grant) at price 304.00 per share. 116 $35,264
2026-05-01 TYLER LAUREN M. Director Stock Award(Grant) at price 304.00 per share. 99 $30,096
2026-05-01 COOPER ELLEN Director Stock Award(Grant) at price 304.00 per share. 99 $30,096
2026-03-11 CAMPBELL ELIZABETH S Officer 12,623
2026-03-11 BATTAGLIA SILVANA Officer 8,415
2026-03-11 CLEARY JAMES F. JR. Chief Financial Officer 12,623
2026-03-05 MILLER REDONDA M.D. Director Stock Award(Grant) at price 359.28 per share. 557 $200,119
2026-03-05 NALLY DENNIS M Director Stock Award(Grant) at price 359.22 - 359.28 per share. 655 $235,323
2026-03-05 CLYBURN FRANKLIN KING JR. Director Stock Award(Grant) at price 359.28 per share. 557 $200,119
2026-03-05 TYLER LAUREN M. Director Stock Award(Grant) at price 359.22 - 359.28 per share. 641 $230,293
2026-03-05 GREENBERG LON R Director Stock Award(Grant) at price 359.28 per share. 557 $200,119
2026-03-05 DURCAN DERMOT MARK Director Stock Award(Grant) at price 359.28 per share. 905 $325,148
2026-03-05 RYERKERK LORI J Director Stock Award(Grant) at price 359.28 per share. 557 $200,119
2026-03-05 COOPER ELLEN Director Stock Award(Grant) at price 359.22 - 359.28 per share. 692 $248,614
2026-02-20 MAUCH ROBERT P. Chief Executive Officer Conversion of Exercise of derivative security at price 86.09 per share. 3,762 $323,871
2026-02-20 MAUCH ROBERT P. Chief Executive Officer Sale at price 358.94 per share. 3,762 $1,350,332
2026-02-18 MAUCH ROBERT P. Chief Executive Officer Sale at price 359.46 per share. 1,333 $479,160
2026-01-20 MAUCH ROBERT P. Chief Executive Officer Conversion of Exercise of derivative security at price 86.09 per share. 3,763 $323,957
2026-01-20 MAUCH ROBERT P. Chief Executive Officer Sale at price 354.73 per share. 5,096 $1,807,704
2025-12-31 BATTAGLIA SILVANA Officer Stock Award(Grant) at price 287.09 per share. 27 $7,850
BATTAGLIA SILVANA Officer
Stock Award(Grant) at price 240.53 per share.
2026-06-30 58 sh $14,000
CAMPBELL ELIZABETH S Officer
Stock Award(Grant) at price 240.53 per share.
2026-06-30 49 sh $12,000
TYLER LAUREN M. Director
Purchase at price 270.23 per share.
2026-06-22 550 sh $148,626
DURCAN DERMOT MARK Director
Purchase at price 274.19 per share.
2026-06-18 4,000 sh $1,096,760
DURCAN DERMOT MARK Director
Purchase at price 266.26 per share.
2026-05-28 4,000 sh $1,065,040
NALLY DENNIS M Director
Stock Award(Grant) at price 304.00 per share.
2026-05-01 116 sh $35,264
TYLER LAUREN M. Director
Stock Award(Grant) at price 304.00 per share.
2026-05-01 99 sh $30,096
COOPER ELLEN Director
Stock Award(Grant) at price 304.00 per share.
2026-05-01 99 sh $30,096
CAMPBELL ELIZABETH S Officer
2026-03-11 12,623 sh
BATTAGLIA SILVANA Officer
2026-03-11 8,415 sh
CLEARY JAMES F. JR. Chief Financial Officer
2026-03-11 12,623 sh
MILLER REDONDA M.D. Director
Stock Award(Grant) at price 359.28 per share.
2026-03-05 557 sh $200,119
NALLY DENNIS M Director
Stock Award(Grant) at price 359.22 - 359.28 per share.
2026-03-05 655 sh $235,323
CLYBURN FRANKLIN KING JR. Director
Stock Award(Grant) at price 359.28 per share.
2026-03-05 557 sh $200,119
TYLER LAUREN M. Director
Stock Award(Grant) at price 359.22 - 359.28 per share.
2026-03-05 641 sh $230,293
GREENBERG LON R Director
Stock Award(Grant) at price 359.28 per share.
2026-03-05 557 sh $200,119
DURCAN DERMOT MARK Director
Stock Award(Grant) at price 359.28 per share.
2026-03-05 905 sh $325,148
RYERKERK LORI J Director
Stock Award(Grant) at price 359.28 per share.
2026-03-05 557 sh $200,119
COOPER ELLEN Director
Stock Award(Grant) at price 359.22 - 359.28 per share.
2026-03-05 692 sh $248,614
MAUCH ROBERT P. Chief Executive Officer
Conversion of Exercise of derivative security at price 86.09 per share.
2026-02-20 3,762 sh $323,871
MAUCH ROBERT P. Chief Executive Officer
Sale at price 358.94 per share.
2026-02-20 3,762 sh $1,350,332
MAUCH ROBERT P. Chief Executive Officer
Sale at price 359.46 per share.
2026-02-18 1,333 sh $479,160
MAUCH ROBERT P. Chief Executive Officer
Conversion of Exercise of derivative security at price 86.09 per share.
2026-01-20 3,763 sh $323,957
MAUCH ROBERT P. Chief Executive Officer
Sale at price 354.73 per share.
2026-01-20 5,096 sh $1,807,704
BATTAGLIA SILVANA Officer
Stock Award(Grant) at price 287.09 per share.
2025-12-31 27 sh $7,850